Company Profile
Sigilon is a clinical-stage biotechnology company pioneering a new class of therapeutics and seeking to develop functional cures for patients with chronic diseases.
Stock chart goes here
Stock Quote
Price
$X.XX
Change
$X.XX
High
$XX.XX
Market Cap
$XX